Trends in meningococcal disease: challenges for vaccine control when disease is rare
The clinical, social and economic value of vaccination varies both with time and by population group <br/> In most wealthy and in many middle income countries, capsular group B Neisseria meningitidis (MenB) remains an important cause of invasive disease, particularly in the era of control of o...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Australasian Medical Publishing Company
2017
|
| _version_ | 1797065097366994944 |
|---|---|
| author | Pollard, A Christensen, H |
| author_facet | Pollard, A Christensen, H |
| author_sort | Pollard, A |
| collection | OXFORD |
| description | The clinical, social and economic value of vaccination varies both with time and by population group <br/> In most wealthy and in many middle income countries, capsular group B Neisseria meningitidis (MenB) remains an important cause of invasive disease, particularly in the era of control of other major bacterial pathogens, such as MenC, Haemophilus influenzae type b, and vaccine-type pneumococcus. Two new MenB vaccines (now licensed in many countries) provide the potential for a comprehensive approach to controlling these invasive bacterial pathogens. However, decisions about vaccination at the population level are complex when there are low rates of disease: cost-effectiveness is a particularly important factor. |
| first_indexed | 2024-03-06T21:23:46Z |
| format | Journal article |
| id | oxford-uuid:4261f43e-ed8d-4b3a-8974-7d5fe755e941 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:23:46Z |
| publishDate | 2017 |
| publisher | Australasian Medical Publishing Company |
| record_format | dspace |
| spelling | oxford-uuid:4261f43e-ed8d-4b3a-8974-7d5fe755e9412022-03-26T14:49:09ZTrends in meningococcal disease: challenges for vaccine control when disease is rareJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4261f43e-ed8d-4b3a-8974-7d5fe755e941EnglishSymplectic Elements at OxfordAustralasian Medical Publishing Company2017Pollard, AChristensen, HThe clinical, social and economic value of vaccination varies both with time and by population group <br/> In most wealthy and in many middle income countries, capsular group B Neisseria meningitidis (MenB) remains an important cause of invasive disease, particularly in the era of control of other major bacterial pathogens, such as MenC, Haemophilus influenzae type b, and vaccine-type pneumococcus. Two new MenB vaccines (now licensed in many countries) provide the potential for a comprehensive approach to controlling these invasive bacterial pathogens. However, decisions about vaccination at the population level are complex when there are low rates of disease: cost-effectiveness is a particularly important factor. |
| spellingShingle | Pollard, A Christensen, H Trends in meningococcal disease: challenges for vaccine control when disease is rare |
| title | Trends in meningococcal disease: challenges for vaccine control when disease is rare |
| title_full | Trends in meningococcal disease: challenges for vaccine control when disease is rare |
| title_fullStr | Trends in meningococcal disease: challenges for vaccine control when disease is rare |
| title_full_unstemmed | Trends in meningococcal disease: challenges for vaccine control when disease is rare |
| title_short | Trends in meningococcal disease: challenges for vaccine control when disease is rare |
| title_sort | trends in meningococcal disease challenges for vaccine control when disease is rare |
| work_keys_str_mv | AT pollarda trendsinmeningococcaldiseasechallengesforvaccinecontrolwhendiseaseisrare AT christensenh trendsinmeningococcaldiseasechallengesforvaccinecontrolwhendiseaseisrare |